9 Meters Biopharma, Inc. (NMTRQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Aug 13, 2025, 8:00 PM EDT
9 Meters Biopharma Market Cap
9 Meters Biopharma has a market cap or net worth of $14.00 as of August 15, 2025. Its market cap has decreased by -99.99% in one year.
Market Cap
14.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since February 2, 2018, 9 Meters Biopharma's market cap has decreased from 125.90M to 14.00, a decrease of -100.00%. That is a compound annual growth rate of -88.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 14.00 | - |
| Dec 31, 2024 | 14.00 | - |
| Dec 29, 2023 | 14.00 | -100.00% |
| Dec 30, 2022 | 16.32M | -93.48% |
| Dec 31, 2021 | 250.22M | 43.21% |
| Dec 31, 2020 | 174.72M | 774.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 2, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.72M |
| Veradigm | 798.20M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 608.19M |
| Glass House Brands | 543.74M |
| Northwest Biotherapeutics | 349.08M |
| American Oncology Network | 337.45M |
| CytoDyn | 300.87M |